Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial.
Sarah Louise DombernowskyBirgitte Bentz DamholtMichael Højby RasmussenClaus SværkeRasmus Juul KildemoesPublished in: Clinical pharmacokinetics (2024)
ClinicalTrials.gov, NCT03905850 (3 April 2019).